After earning her biochemistry and biotechnology bachelor’s, Allison Lendman is staying at UMSL in an accelerated master’s ...

Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...

ADC payload with a differentiated mechanism of actionCombines oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad potential across multiple solid tumour ...

Graduates earn places at world-leading universities across the UK, US, Europe, Australia, Hong Kong and the UAE Results ...

Vietnam's 2026 high school graduation exam produced 11 national toppers and 47 runners-up across the country's five ...

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

US FDA grants breakthrough therapy designation for INTENT Biologics’ PEP Biologic to treat diabetic foot ulcers: Rochester, Minnesota Friday, July 3, 2026, 09:00 Hrs [IST] INTEN ...

Talawar Therapeutics and JATT II enter definitive business combination agreement to create publicly listed biotechnology company: New York Wednesday, July 1, 2026, 16:00 Hrs [IST] ...

Myricx Bio, a cancer therapy spinout from Imperial’s Department of Chemistry, today announced it has reached agreement to be ...